Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miao Mo

Showing results (21-30 of 127) with videos related to

Pageof 13
Sort By:
Translational Andrology and Urology|February 3, 2021
LncRNA SNHG9 is a prognostic biomarker and correlated with immune infiltrates in prostate cancerChao Li, Jiao Hu, Xiheng Hu, et al.
European Journal of Cancer (Oxford, England : 1990)|September 19, 2019
Comparison of treatment effect from randomised controlled phase II trials and subsequent phase III trials using identical regimens in the same treatment settingFei Liang, Zhenyu Wu, Miao Mo, et al.
Oncotarget|January 20, 2017
Low rate of positive margins and re-excision after partial mastectomy in highly selected breast cancer patients: A Chinese single-institution experienceSiyu Wu, Yanyan Zhu, Zhaozhi Yang, et al.
Translational Cancer Research|February 4, 2022
MEST promotes bladder cancer cell proliferation, migration and invasion via STAT3/Twist-1-mediated EMTCheng Zhao, Xiheng Hu, Shiyu Tong, et al.
Cancer Biology & Medicine|April 5, 2022
Breast cancer screening and early diagnosis in Chinese womenRui Ding, Yi Xiao, Miao Mo, et al.
Translational Cancer Research|February 4, 2022
Long noncoding RNA MAFG-AS1 facilitates bladder cancer tumorigenesis via regulation of miR-143-3p/SERPINE1 axisXi Sun, Yi Cai, Xiheng Hu, et al.
Frontiers in Molecular Biosciences|March 5, 2021
Zic Family Member 2 (ZIC2): a Potential Diagnostic and Prognostic Biomarker for Pan-CancerZhengtong Lv, Lin Qi, Xiheng Hu, et al.
NPJ Precision Oncology|August 18, 2020
Tailored duration of adjuvant trastuzumab for human epidermal growth factor receptor 2-positive breast cancerKe-Da Yu, Xin Wang, Wan-Kun Chen, et al.
Frontiers in Public Health|August 14, 2023
Predictors of cancer screening behavior of the working population in China based on the information-motivation-behavioral skills modelZezhou Wang, Changming Zhou, Li Zhang, et al.
Breast (Edinburgh, Scotland)|October 15, 2023
Contralateral axillary lymph node metastasis in breast cancer: An oligometastatic-like diseaseQian Zhao, Fan Yang, Huai-Liang Wu, et al.
Pageof 13

Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
Translational Andrology and Urology|February 3, 2021
LncRNA SNHG9 is a prognostic biomarker and correlated with immune infiltrates in prostate cancerChao Li, Jiao Hu, Xiheng Hu, et al.
European Journal of Cancer (Oxford, England : 1990)|September 19, 2019
Comparison of treatment effect from randomised controlled phase II trials and subsequent phase III trials using identical regimens in the same treatment settingFei Liang, Zhenyu Wu, Miao Mo, et al.
Oncotarget|January 20, 2017
Low rate of positive margins and re-excision after partial mastectomy in highly selected breast cancer patients: A Chinese single-institution experienceSiyu Wu, Yanyan Zhu, Zhaozhi Yang, et al.
Translational Cancer Research|February 4, 2022
MEST promotes bladder cancer cell proliferation, migration and invasion via STAT3/Twist-1-mediated EMTCheng Zhao, Xiheng Hu, Shiyu Tong, et al.
Cancer Biology & Medicine|April 5, 2022
Breast cancer screening and early diagnosis in Chinese womenRui Ding, Yi Xiao, Miao Mo, et al.
Translational Cancer Research|February 4, 2022
Long noncoding RNA MAFG-AS1 facilitates bladder cancer tumorigenesis via regulation of miR-143-3p/SERPINE1 axisXi Sun, Yi Cai, Xiheng Hu, et al.
Frontiers in Molecular Biosciences|March 5, 2021
Zic Family Member 2 (ZIC2): a Potential Diagnostic and Prognostic Biomarker for Pan-CancerZhengtong Lv, Lin Qi, Xiheng Hu, et al.
NPJ Precision Oncology|August 18, 2020
Tailored duration of adjuvant trastuzumab for human epidermal growth factor receptor 2-positive breast cancerKe-Da Yu, Xin Wang, Wan-Kun Chen, et al.
Frontiers in Public Health|August 14, 2023
Predictors of cancer screening behavior of the working population in China based on the information-motivation-behavioral skills modelZezhou Wang, Changming Zhou, Li Zhang, et al.
Breast (Edinburgh, Scotland)|October 15, 2023
Contralateral axillary lymph node metastasis in breast cancer: An oligometastatic-like diseaseQian Zhao, Fan Yang, Huai-Liang Wu, et al.
Pageof 13